AzTrials
AzTrials

PrematurityNCT01600586

A Clinical Trial of A Pacifier-Activated Music Player

A study testing Pacifier-Activated-Lullaby system (PAL). in people with Prematurity, run by Vanderbilt University Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Neonatal intensive care unit infants are at high risk for oromotor difficulties including poor coordination of sucking swallowing and breathing. These feeding difficulties often result in prolonged hospitalization, with increased physiologic stressors and poor growth. Read more about this study

Who is it for?
Ages 34 to 36 weeks
Conditions the study is for
Prematurity
What is being tested?
Pacifier-Activated-Lullaby system (PAL).
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
Apr 2012to Jun 2013
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 34 to 36 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • All infants at 34 0/7 to 35 6/7 weeks post-conceptional age cared for in the Vanderbilt NICU who are receiving more than 50 % of their nutrition as enteral feeds, and are in individual rooms or in the room with their sibling.

Who cannot join

  • infants on ventilators or Continuous Positive Airway Pressure (CPAP),
  • infants determined to be unsafe to feed orally by the medical team or the feeding/speech specialists at Vanderbilt.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Monroe Carell Jr. Children's Hospital at Vanderbilt

    Nashville, Tennessee, 37232

Other trials in United States

About this study

Official title: A Pacifier-Activated Music Player With Mother's Voice Improves Oral Feeding in Preterm Infants

Neonatal intensive care unit infants are at high risk for oromotor difficulties including poor coordination of sucking swallowing and breathing. These feeding difficulties often result in prolonged hospitalization, with increased physiologic stressors and poor growth. In preliminary studies, Pacifier Activated Lullaby (PAL) use showed potential increased oromotor skills and decreased length of hospitalization.

The investigators propose to test the hypothesis that a week-long PAL intervention can improve feeding skills and decrease stress compared to standard of care parental interactions in infants in the late preterm period. The investigators also hypothesize that these improvements will result in shorter hospital stays and increased growth in the intervention group.

Our study design is a prospective randomized controlled trial design of 94 infants (Post-conceptional ages 34-36 weeks). The 47 intervention-group infant/mother dads will receive a book library with one lullaby book and record her voice to the PAL, which the music therapist will then administer in 15-minute sessions for 5 consecutive days. The 47 participants in the control group will receive the same library but no recording will be made or PAL used. Outcomes measured will include time to full oral feeds, suck rate and efficiency, salivary cortisol levels before and after intervention, daily growth parameters and nutritional data, and hospital length of stay.

Read the detailed description

Objectives: We conducted a randomized trial to test the hypothesis that the mother's voice played through a pacifier-activated music (PAM) player during nonnutritive sucking would improve the development of sucking ability and promote more effective oral feeding in preterm infants.

Methods: Preterm infants between 34 0/7 and 35 6/7 weeks postmenstrual age, including those with brain injury, who were taking at least half their feedings enterally and less than half orally, were randomly assigned to receive 5 daily 15-minute sessions of either PAM with mother's recorded voice or no PAM, along with routine nonnutritive sucking and maternal care in both groups. Assignment was masked to the clinical team.

Conditions
Prematurity
Being tested
Pacifier-Activated-Lullaby system (PAL).
Keywords
Neonatal Intensive Care Unit (NICU), Music therapy, Premature infant, Oral feeds, Non-Nutritive Sucking, Suck rate, Suck efficiency, Contingent music, Mother's voice
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pacifier-Activated-Lullaby system (PAL).Device

    Pacifier-Activated-Lullaby system (PAL).

Study groups in NCT01600586
Study groupRoleWhat they receive
Pacifier-Activated-Lullaby system (PAL)ExperimentalPacifier-Activated-Lullaby system (PAL) group.
Receives: Device: Pacifier-Activated-Lullaby system (PAL).
No PAL groupNo interventionNo PAL. Standard of care procedures.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Suck Rate and Efficiency: Change From Pre-test (Day 0) to Post-test (Day 5)

    Feeding rate when nippling was calculated by dividing the number of cc of nippled nutrition by time for consumption. This data was recorded at two time points: pre and post intervention

    Measured: Day 0, and Day 5

Secondary outcomes (4)
  1. Discharge Weight

    Description: Growth measures.

    Measured: day of hospital discharge (approximately 5-7 weeks)

  2. Change From Pre-test(Day 0)in Salivary Cortisol Levels to Post-test (Day 5)

    Description: Stress: Salivary cortisol levels at baseline and after 1 week of PAL in the intervention group.

    Measured: Day 0, and Day 5

  3. Hospital Length of Stay

    Description: Data on hospital stay was recorded from the chart. The participants were be followed for the duration of the hospital stay from the time of consent for participation to the time discharge from the NICU is documented.

    Measured: days from consent to discharge

  4. Number of Days to Full Oral Feeds

    Aim: Quantify the effect of the PAL intervention on efficiency of sucking and time to reaching full oral feeds in comparison to controls. Data on the number of days from Day 0 of the study to the date of first documented full oral feed, up to 70 days (or date of death from any cause) were be recorded from the chart.

    Measured: Day 0 of the study to the date of first documented full oral feed (up to 70 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2012 (estimated)
  2. Study startApr 2012
  3. Primary completionJun 2013
  4. Study completionJun 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01600586
Sponsor's protocol ID
VKC 4-30-100-9622
Other IDs
UL1RR024975-01
Status last verified
Apr 2018
First submitted
9 May 2012
Last updated
7 May 2018
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Pacifier-Activated-Lullaby system (PAL). in people with Prematurity, run by Vanderbilt University Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 7 May 2018). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Suck Rate and Efficiency: Change From Pre-test (Day 0) to Post-test (Day 5) (time frame: Day 0, and Day 5). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in